Wedbush Securities Inc Novartis Ag Transaction History

Wedbush Securities Inc

  • $2.86 Billion
  • Q2 2025

A detailed history of Wedbush Securities Inc transactions in Novartis Ag stock. As of the latest transaction made, Wedbush Securities Inc holds 3,695 shares of NVS stock, worth $440,850. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,695
Previous 3,362 9.9%
Holding current value
$440,850
Previous $375,000 19.2%
% of portfolio
0.02%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025
BUY
$101.96 - $121.01 $33,952 - $40,296
333 Added 9.9%
3,695 $447,000
Q1 2025

May 06, 2025
BUY
$97.14 - $115.57 $13,502 - $16,064
139 Added 4.31%
3,362 $375,000
Q4 2024

Feb 12, 2025
SELL
$96.78 - $117.18 $41,905 - $50,738
-433 Reduced 11.84%
3,223 $314,000
Q3 2024

Nov 08, 2024
SELL
$106.13 - $120.89 $620,542 - $706,843
-5,847 Reduced 61.53%
3,656 $421,000
Q2 2024

Aug 06, 2024
SELL
$92.57 - $107.37 $189,953 - $220,323
-2,052 Reduced 17.76%
9,503 $1.01 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $538,751 - $613,397
5,655 Added 95.85%
11,555 $1.12 Million
Q4 2023

Feb 12, 2024
SELL
$92.27 - $101.54 $10,149 - $11,169
-110 Reduced 1.83%
5,900 $596,000
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $89,614 - $99,452
-946 Reduced 13.6%
6,010 $612,000
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $33,584 - $38,082
-363 Reduced 4.96%
6,956 $702,000
Q1 2023

May 09, 2023
BUY
$80.03 - $92.81 $36,253 - $42,042
453 Added 6.6%
7,319 $673,000
Q4 2022

Jan 31, 2023
SELL
$75.55 - $92.52 $9,066 - $11,102
-120 Reduced 1.72%
6,866 $623,000
Q3 2022

Oct 18, 2022
SELL
$74.61 - $87.26 $370,364 - $433,158
-4,964 Reduced 41.54%
6,986 $531,000
Q2 2022

Jul 21, 2022
BUY
$80.52 - $93.75 $14,413 - $16,781
179 Added 1.52%
11,950 $1.01 Million
Q1 2022

Apr 19, 2022
SELL
$80.11 - $90.62 $48,386 - $54,734
-604 Reduced 4.88%
11,771 $1.03 Million
Q4 2021

Jan 13, 2022
SELL
$79.7 - $88.13 $150,314 - $166,213
-1,886 Reduced 13.22%
12,375 $1.08 Million
Q3 2021

Oct 08, 2021
BUY
$81.78 - $95.14 $1,226 - $1,427
15 Added 0.11%
14,261 $1.17 Million
Q2 2021

Jul 27, 2021
SELL
$85.24 - $94.15 $51,570 - $56,960
-605 Reduced 4.07%
14,246 $1.3 Million
Q1 2021

Apr 26, 2021
BUY
$83.5 - $98.47 $172,093 - $202,946
2,061 Added 16.11%
14,851 $1.27 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $55,195 - $66,762
-707 Reduced 5.24%
12,790 $1.21 Million
Q3 2020

Oct 20, 2020
SELL
$82.14 - $91.0 $96,925 - $107,380
-1,180 Reduced 8.04%
13,497 $1.17 Million
Q2 2020

Jul 16, 2020
SELL
$80.93 - $91.1 $197,550 - $222,375
-2,441 Reduced 14.26%
14,677 $1.28 Million
Q1 2020

Apr 17, 2020
SELL
$70.67 - $99.01 $108,761 - $152,376
-1,539 Reduced 8.25%
17,118 $1.41 Million
Q4 2019

Jan 16, 2020
BUY
$84.35 - $95.37 $17,291 - $19,550
205 Added 1.11%
18,657 $1.77 Million
Q3 2019

Oct 17, 2019
BUY
$85.54 - $94.26 $42,513 - $46,847
497 Added 2.77%
18,452 $1.6 Million
Q2 2019

Aug 01, 2019
BUY
$75.4 - $92.8 $98,020 - $120,640
1,300 Added 7.81%
17,955 $1.64 Million
Q1 2019

Apr 17, 2019
BUY
$75.32 - $86.15 $36,304 - $41,524
482 Added 2.98%
16,655 $1.6 Million
Q4 2018

Jan 31, 2019
SELL
$73.66 - $82.02 $102,092 - $113,679
-1,386 Reduced 7.89%
16,173 $1.39 Million
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $54,823 - $63,415
-819 Reduced 4.46%
17,559 $1.51 Million
Q2 2018

Aug 03, 2018
SELL
$64.91 - $73.36 $115,929 - $131,020
-1,786 Reduced 8.86%
18,378 $1.39 Million
Q1 2018

May 01, 2018
SELL
$70.39 - $84.15 $36,813 - $44,010
-523 Reduced 2.53%
20,164 $1.63 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $39,419 - $42,313
545 Added 2.71%
20,687 $1.74 Million
Q3 2017

Oct 31, 2017
BUY
$74.14 - $77.27 $1.49 Million - $1.56 Million
20,142
20,142 $1.73 Million

Others Institutions Holding NVS

# of Institutions
1,550
Shares Held
140M
Call Options Held
1.69M
Put Options Held
1.87M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $257B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email